Nurofen Plus, for pain and fever, 12 coated tablets

Nurofen Plus is a medicine that contains the active substance – ibuprofen, which belongs to the group of non-steroidal anti-inflammatory drugs (NSAIDs), which have the ability to reduce such ailments as pain and fever. Codeine , the second active substance of Nurofen Plus, is a strong painkiller.

The combination of ibuprofen and codeine in Nurofen Plus provides a combined analgesic effect.

The drug is indicated for use in the following cases:

• rheumatic and muscular pain, back pain, neuralgia, migraine, headaches, toothache, painful menstruation;
• fever due to a cold or flu.

The active substances of the drug are ibuprofen and codeine phosphate hemihydrate – 1 coated tablet contains 200 mg of ibuprofen and 12.8 mg of codeine phosphate hemihydrate.

Excipients are:

• tablet core: microcrystalline cellulose, sodium carboxymethyl starch, pregelatinized starch, hypromellose;
• tablet coating: hypromellose, talc, Opaspray white M-1-7111B (titanium dioxide (E 171), hypromellose).

• Adults and children over 12 years of age should take 1 to 2 tablets every 6 hours.
• Swallow the tablets with some liquid.
• Do not take more than 6 tablets in 24 hours.
• The medicine should not be taken for longer than 3 days. If the pain does not subside after 3 days, consult a doctor.

Always use Nurofen Plus exactly as described in the package leaflet or as directed by your doctor or pharmacist.

Nurofen Plus should not be used in patients:

• with hypersensitivity to ibuprofen, codeine or any of the excipients of the drug and to other non-steroidal anti-inflammatory drugs;
• who have ever had allergy symptoms such as runny nose, hives or bronchial asthma after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs;
• with active gastric and/or duodenal ulcer or a history of perforation or bleeding, also associated with the use of non-steroidal anti-inflammatory drugs;
• with severe hepatic failure, severe renal failure or severe heart failure;
• taking other non-steroidal anti-inflammatory drugs, including COX-2 inhibitors (increased risk of side effects;
• in the third trimester of pregnancy;
• with bleeding diathesis;
• with breathing disorders;
• with chronic constipation;
• for pain relief in children and adolescents (aged 0 to 18 years) following removal of palatine or pharyngeal tonsils due to obstructive sleep apnea syndrome;
• if the patient knows that he or she metabolizes codeine into morphine very quickly;
• if you are breastfeeding.